PRICE T ROWE ASSOCIATES INC /MD/

Position in RLMD — Relmada Therapeutics, Inc.

CIK 80255 BALTIMORE, MD

Position in RLMD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$537,462

+$59,592 QoQ

Shares Held

77,668

-51.2% QoQ

Ownership

0.073%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#69

of 126 holders

Holding Since

Sep 2021

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. RLMD ranks #207 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	2,678,047	$2,484,611,664
2	REGN	Regeneron Pharmaceuticals, Inc.	1,529,709	$953,834,749
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,728,421	$858,558,562
4	KYMR	Kymera Therapeutics, Inc.	7,112,980	$815,645,416
5	RPRX	Royalty Pharma plc	11,193,657	$627,628,347
6	RVMD	Revolution Medicines, Inc.	2,969,853	$447,655,945
7	MRNA	Moderna, Inc.	5,589,560	$391,436,886
8	TWST	Twist Bioscience Corp	3,634,652	$373,932,997

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$537,462	77,668	-51.2%	Shares	Defined	2026-08-14
2023-09-30	$477,870	159,290	-1.9%	Shares	Sole	2023-11-14
2023-06-30	$399,592	162,436	-9.0%	Shares	Sole	2023-08-14
2023-03-31	$403,274	178,440	-4.8%	Shares	Sole	2023-05-15
2022-12-31	$654,231	187,459	-4.6%	Shares	Sole	2023-02-14
2022-09-30	$7,276,502	196,556	+16.5%	Shares	Sole	2022-11-14
2022-06-30	$3,204,695	168,757	+7.1%	Shares	Sole	2022-08-15
2022-03-31	$4,252,679	157,565	+1855.6%	Shares	Sole	2022-05-16
2021-09-30	$211,173	8,057	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.